Ind-Swift Laboratories (NSE:INDSWFTLAB) Accounts Payable : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Accounts Payable?

Ind-Swift Laboratories's Accounts Payable for the quarter that ended in Dec. 2023 was ₹0 Mil.

Ind-Swift Laboratories's quarterly Accounts Payable increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹1,842 Mil) but then declined from Sep. 2023 (₹1,842 Mil) to Dec. 2023 (₹0 Mil).

Ind-Swift Laboratories's annual Accounts Payable increased from Mar. 2021 (₹1,388 Mil) to Mar. 2022 (₹1,760 Mil) and increased from Mar. 2022 (₹1,760 Mil) to Mar. 2023 (₹2,040 Mil).

Ind-Swift Laboratories Accounts Payable Historical Data

The historical data trend for Ind-Swift Laboratories's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Accounts Payable Chart

Ind-Swift Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable

Get a 7-Day Free Trial

1,266.80

1,352.26

1,388.21

1,759.53

2,039.94

Ind-Swift Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															-	2,039.94	-	1,841.79	-

Ind-Swift Laboratories Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Ind-Swift Laboratories Accounts Payable Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Accounts Payable

Traded in Other Exchanges

532305:India

Address

SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101

Website

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines